Theriva Biologics Inc.
TOVX
$0.24+1.02%
End of day · as of Aug 25, 2026, 6:03 PM ET
Mkt cap
$12.39M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-03-31)
$300,000
EPS (H1 2026)
$-0.12
Gross Margin (qtr ended 2026-03-31)
N/A
Profit Margin (qtr ended 2026-03-31)
-681.33%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported TOVX revenue for 2026-03-31 was $300.0K. Net income was -$2.0M. TOVX currently screens at market cap $12.4M.
Use this TOVX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TOVX income, balance, and cash tables.
Theriva Biologics Inc. (TOVX) is a biotechnology company in the Healthcare sector.
Latest cached Theriva Biologics Inc. (TOVX) revenue for Mar 31, 2026 was $300.0K. Net income was -$2.0M. Statements: https://lician.com/financials/tovx
Theriva Biologics Inc. (TOVX) market capitalization is $12.4M on the latest cached snapshot.
Theriva Biologics Inc. (TOVX) cached previous close $0.24; day range $0.24 – $0.25; volume 363,046. Session quote: https://lician.com/quote/tovx
Theriva Biologics Inc. (TOVX) latest cached earnings event is "TOVX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TOVX filing is 8-K · Aug 11, 2026. Filings: https://lician.com/sec/tovx